May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Extravascular in situ Thrombolytic (r-TPA) Application for the Management of Retinal Vein Thrombosis- Short Term Results
Author Affiliations & Notes
  • E.V. Christodoulakis
    Ophthalmology Clinic, University Hospital, Heraklion, Crete, Greece
  • M.K. Tsilimbaris
    Ophthalmology Clinic, University Hospital, Heraklion, Crete, Greece
  • V.A. Panteleontidis
    Vardinoghiannion Eye Institute of Crete, (V.E.I.C.), Heraklion, Crete, Greece
  • I.G. Pallikaris
    Vardinoghiannion Eye Institute of Crete, (V.E.I.C.), Heraklion, Crete, Greece
  • Footnotes
    Commercial Relationships  E.V. Christodoulakis, None; M.K. Tsilimbaris, None; V.A. Panteleontidis, None; I.G. Pallikaris, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 4054. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E.V. Christodoulakis, M.K. Tsilimbaris, V.A. Panteleontidis, I.G. Pallikaris; Extravascular in situ Thrombolytic (r-TPA) Application for the Management of Retinal Vein Thrombosis- Short Term Results . Invest. Ophthalmol. Vis. Sci. 2003;44(13):4054.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the safety and the efficacy of extravascular in situ thrombolytic application (r-TPA) for the management of central and branch retinal vein thrombosis. Methods: Five patients, 3 males and 2 females, 3 with CVO and 2 BVOs, 66 to 80 years old, were operated between May and Nov 2002. The technique included three port vitrectomy with posterior vitreous detachment, fluid-air exchange, and finally infusion of 50 µg r-TPA in 0.5 ml water for injection solution. All patients were advised for supine position for 6 hours after surgery. Results: The follow-up period after surgery ranged from 1 to 6 months (mean: 3.6 months). Visual acuity remained stable in 3 patients and improved in the rest. Intraretinal hemorrhages and edema improved in all patients. One patient presented faint intravitreal hemorrhage that resolved spontaneously during the first postoperative month. Conclusions: This novel approach seems to be safe and promising for the management of retinal vein thrombosis. More patients and longer follow-up are necessary for the evaluation of the clinical results of the technique.

Keywords: vascular occlusion/vascular occlusive disease • retina • vitreoretinal surgery 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×